We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Portable, Pocket-Sized A1c Testing Device Delivers Results in 5 Minutes From Single Blood Drop

By HospiMedica International staff writers
Posted on 21 Apr 2023
Print article
Image: The OBM rapid A1c guided, reusable system makes routine testing easier (Photo courtesy of Orange Biomed)
Image: The OBM rapid A1c guided, reusable system makes routine testing easier (Photo courtesy of Orange Biomed)

Diabetes stands as a primary contributor to mortality rates and accounts for a significant portion of healthcare expenses, primarily related to diabetes-related comorbidities. These comorbidities can range from neurological and cardiovascular to renal issues and chronic kidney disease (CKD). Consequently, it is crucial to ensure patients have adequate access to HbA1c testing. Point-of-care (POC) A1c devices can efficiently and accurately determine patients' A1c levels, offering an affordable and user-friendly option for healthcare professionals of all backgrounds and experience levels. Now, a cutting-edge portable glycated hemoglobin analyzer employs single-cell analysis of red blood cells to provide immediate and precise HbA1c testing at POC, facilitating real-time diagnosis and monitoring of diabetes.

The OBM rapid A1c from Orange Biomed (Seoul, South Korea) is a compact, portable A1c testing device that requires just a single drop of blood. This user-friendly, palm-sized device does not require prior training or experience, making it ideal for addressing crucial testing needs for individuals with pre-diabetes and diabetes. Utilizing microfluidic technology, the OBM Rapid A1c remains unaffected by potential inconsistencies in sampling volume, and its test results are not influenced by hemoglobin variants, unlike other POC tests. This pioneering approach ensures accurate assessment every time, regardless of the test administrator or recipient.

Besides its portability and exceptional accuracy, the OBM Rapid A1c meter boasts an unlimited shelf life, and its cartridges remain functional for two years. The meter can be reused without the need for maintenance or calibration, making it an ideal all-in-one solution for primary care physicians, endocrinologists, and cardiologists. The reusable system allows healthcare professionals to quickly test multiple patients, streamlining the process across healthcare environments. The OBM Rapid A1c is currently undergoing global studies, and Orange Biomed aims to obtain FDA clearance within the next year.

“OBM rapid A1c is a portable, guided, five-minute test requiring only a single drop of blood to produce accurate results,” said Orange Biomed co-founder Yeaseul Park. “By seamlessly integrating lab-level technology into portable devices, we seek to make healthcare more accessible, accurate, and affordable for everyone.”

Related Links:
Orange Biomed 

New
Gold Supplier
Conductive Gel
Tensive
New
Lesion Tracking Application
Sectra Lesion Tracking
New
Oxygen Therapy Hyperbaric Chamber
Sechrist 2800
New
Silver Supplier
Patient Simulator
PatSim 200

Print article
FIME - Informa

Channels

AI

view channel
Image: The AI tool can also tackle dangerous inequalities in heart attack diagnosis (Photo courtesy of Freepik)

AI Algorithm Integrates Cardiac Troponin Test Results with Clinical Data to Quickly Rule out Heart Attacks in Patients

The accepted standard for diagnosing myocardial infarction, or heart attack, involves assessing the blood for troponin levels. However, this approach applies the same benchmark for all patients, failing... Read more

Critical Care

view channel
Image: Chest e-tattoo boasts major improvements in heart monitoring (Photo courtesy of UT)

Chest E-Tattoo for Continuous, Mobile Heart Monitoring Could Catch Cardiovascular Diseases Early

Most heart-related ailments are insidious in nature, damaging health quietly and unnoticed. Continuous, at-home mobile monitoring can lead to early diagnosis and treatment, potentially preventing up to... Read more

Surgical Techniques

view channel
Image: RefluxStop treats acid reflux without affecting the food passageway (Photo courtesy of Implantica AG)

Breakthrough Implant Marks Paradigm Shift in Treatment of Gastroesophageal Reflux

Acid reflux, a condition characterized by the regurgitation of the stomach's acid content into the esophagus, affects approximately 400 million individuals daily, making it the second-largest treatment... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.